Phase 1 data published in Nature Communications show potential of mRNA encoding VEGF-A
Moderna announced publication of a Phase 1a/b study in Nature Communications showing the potential of mRNA encoding for vascular endothelial growth factor A (VEGF-A) as a regenerative therapeutic. This approach aims to stimulate the growth of new blood vessels to improve blood flow in tissues. February 20, 2019